NASDAQ:INNV InnovAge (INNV) Stock Price, News & Analysis $5.92 -0.07 (-1.17%) (As of 03:38 PM ET) Add Compare Share Share Today's Range$5.83▼$6.0450-Day Range$5.01▼$6.3652-Week Range$3.52▼$7.49Volume22,104 shsAverage Volume37,790 shsMarket Capitalization$805.05 millionP/E RatioN/ADividend YieldN/APrice Target$6.50 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends Get InnovAge alerts: Email Address InnovAge MarketRank™ Stock AnalysisAnalyst RatingHold2.00 Rating ScoreUpside/Downside9.8% Upside$6.50 Price TargetShort InterestHealthy1.66% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.84Based on 20 Articles This WeekInsider TradingN/AProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.0.12 out of 5 starsMedical Sector920th out of 927 stocksHealth Services Industry10th out of 10 stocks 1.0 Analyst's Opinion Consensus RatingInnovAge has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 2 hold ratings, and no sell ratings.Amount of Analyst CoverageInnovAge has received no research coverage in the past 90 days.Read more about InnovAge's stock forecast and price target. Previous Next 3.0 Short Interest Percentage of Shares Shorted1.66% of the float of InnovAge has been sold short.Short Interest Ratio / Days to CoverInnovAge has a short interest ratio ("days to cover") of 6.2.Change versus previous monthShort interest in InnovAge has recently decreased by 0.42%, indicating that investor sentiment is improving. Previous Next 0.0 Dividend Strength Dividend YieldInnovAge does not currently pay a dividend.Dividend GrowthInnovAge does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for INNV. Previous Next 2.7 News and Social Media Coverage News SentimentInnovAge has a news sentiment score of 0.84. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.68 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 20 news articles for InnovAge this week, compared to 2 articles on an average week. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, InnovAge insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 0.41% of the stock of InnovAge is held by insiders.Percentage Held by InstitutionsOnly 12.26% of the stock of InnovAge is held by institutions.Read more about InnovAge's insider trading history. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of InnovAge is -24.67, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of InnovAge is -24.67, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioInnovAge has a P/B Ratio of 2.65. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about InnovAge's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Crypto 101 MediaTrillion Dollar Blockchain Shift Could Trigger THIS CoinIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…YES, I WANT THE #1 CRYPTO NOW About InnovAge Stock (NASDAQ:INNV)InnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in their homes and communities. The company manages its business through Program of All-Inclusive Care for the Elderly (PACE) approach. It also offers in-home care services consisting of skilled, unskilled, and personal care; in-center services, such as primary care, physical therapy, occupational therapy, speech therapy, dental services, mental health and psychiatric services, meals, and activities; transportation to the PACE center and third-party medical appointments; and care management. The company serves participants in the United States; and operates PACE centers in Colorado, California, New Mexico, Pennsylvania, and Virginia. The company was formerly known as TCO Group Holdings, Inc. and changed its name to InnovAge Holding Corp. in January 2021. InnovAge Holding Corp. was founded in 2007 and is headquartered in Denver, Colorado.Read More INNV Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart INNV Stock News HeadlinesSeptember 16 at 8:00 AM | globenewswire.comLeading PACE Provider InnovAge Selected to Participate in National Study Focused on Preventing Falls by SeniorsSeptember 15 at 3:49 AM | americanbankingnews.comBrokers Set Expectations for InnovAge Holding Corp.'s Q1 2025 Earnings (NASDAQ:INNV)September 16, 2024 | Brownstone Research (Ad)Introducing the PerceptronOn Wednesday, September 25, I’m putting on my first crypto event in two years to unveil: the Perceptron. This is my AI project that I first conceived of shortly after I recommended Nvidia back in 2016.September 13 at 2:13 AM | americanbankingnews.comInnovAge Holding Corp. (NASDAQ:INNV) to Post FY2026 Earnings of $0.07 Per Share, William Blair ForecastsSeptember 12, 2024 | finance.yahoo.comInnovAge Holding Corp.'s (NASDAQ:INNV) Intrinsic Value Is Potentially 68% Above Its Share PriceSeptember 12, 2024 | msn.comInnovAge Holding Corp. (NASDAQ:INNV) Q4 2024 Earnings Call TranscriptSeptember 12, 2024 | americanbankingnews.comInnovAge (NASDAQ:INNV) Shares Gap Up on Better-Than-Expected EarningsSeptember 10, 2024 | globenewswire.comInnovAge Announces Financial Results for the Fourth Quarter and Fiscal Year Ended June 30, 2024September 16, 2024 | Brownstone Research (Ad)Introducing the PerceptronOn Wednesday, September 25, I’m putting on my first crypto event in two years to unveil: the Perceptron. This is my AI project that I first conceived of shortly after I recommended Nvidia back in 2016.September 8, 2024 | americanbankingnews.comInnovAge (INNV) to Release Earnings on TuesdayAugust 22, 2024 | globenewswire.comCORRECTION -- InnovAge PACE Celebrates Anniversary of Vibrant Sacramento CenterAugust 16, 2024 | globenewswire.comInnovAge PACE Celebrates Anniversary of Vibrant Sacramento CenterAugust 7, 2024 | finance.yahoo.comArdent Health Partners, Inc. (ARDT)June 10, 2024 | globenewswire.comInnovAge Holding Corp. Announces $5.0 Million Share Repurchase ProgramJune 3, 2024 | globenewswire.comInnovAge PACE Recertified as a Great Place to WorkMay 29, 2024 | globenewswire.comInnovAge Celebrates Grand Opening of Orlando's First PACE Center in Partnership with Orlando HealthMay 20, 2024 | globenewswire.comInnovAge Welcomes John Koehn as Senior Vice President of External AffairsMay 9, 2024 | finance.yahoo.comInnovAge Holding Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS LagsSee More Headlines Receive INNV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for InnovAge and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings9/10/2024Today9/16/2024Next Earnings (Estimated)11/05/2024Fiscal Year End6/30/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Health services Sub-IndustryHealthcare Current SymbolNASDAQ:INNV CUSIPN/A CIK1834376 Webwww.innovage.com Phone844-803-8745FaxN/AEmployees2,100Year FoundedN/APrice Target and Rating Average Stock Price Target$6.50 High Stock Price Target$7.00 Low Stock Price Target$6.00 Potential Upside/Downside+8.5%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)($0.24) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-40,670,000.00 Net Margins-2.79% Pretax Margin-2.86% Return on Equity-7.43% Return on Assets-3.96% Debt Debt-to-Equity Ratio0.27 Current Ratio1.25 Quick Ratio1.25 Sales & Book Value Annual Sales$763.86 million Price / Sales1.07 Cash FlowN/A Price / Cash FlowN/A Book Value$2.23 per share Price / Book2.69Miscellaneous Outstanding Shares135,988,000Free Float135,430,000Market Cap$814.57 million OptionableOptionable Beta0.39 (Almost) Everything You Need To Know About The EV MarketClick the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise. Get This Free Report Key ExecutivesMr. Patrick Blair (Age 53)President & CEO Comp: $1.51MMs. Nicole D'Amato (Age 45)Chief Legal Officer & Corporate Secretary Comp: $678.76kDr. Richard A. Feifer FACP (Age 57)M.D., M.P.H., Chief Medical Officer Comp: $588.97kMr. Edward Moore Kennedy Jr. (Age 63)J.D., Independent Director Comp: $100kHon. Marilyn Barbour Tavenner M.H.A. (Age 62)R.N., Independent Director Comp: $120kMr. Benjamin Crowninshield Adams (Age 60)Chief Financial Officer Ms. Christine Bent (Age 53)Chief Operations Officer Ms. Cara BabachicosChief Information OfficerMr. Ryan KubotaDirector of Investor RelationsMs. Olivia PattonChief Compliance OfficerMore ExecutivesKey CompetitorsGuardant HealthNASDAQ:GHHims & Hers HealthNYSE:HIMSConcentra Group Holdings ParentNYSE:CONArdent Health PartnersNYSE:ARDTLifeStance Health GroupNASDAQ:LFSTView All CompetitorsInstitutional OwnershipRenaissance Technologies LLCBought 4,100 shares on 8/9/2024Ownership: 0.100%Rhumbline AdvisersBought 1,793 shares on 8/1/2024Ownership: 0.020%Bank of New York Mellon CorpBought 12,448 shares on 7/26/2024Ownership: 0.043%Accordant Advisory Group IncBought 100,000 shares on 7/19/2024Ownership: 0.074%View All Institutional Transactions INNV Stock Analysis - Frequently Asked Questions How have INNV shares performed this year? InnovAge's stock was trading at $6.00 at the beginning of 2024. Since then, INNV stock has decreased by 1.3% and is now trading at $5.92. View the best growth stocks for 2024 here. How were InnovAge's earnings last quarter? InnovAge Holding Corp. (NASDAQ:INNV) issued its quarterly earnings data on Tuesday, September, 10th. The company reported ($0.01) earnings per share for the quarter, beating analysts' consensus estimates of ($0.02) by $0.01. The business earned $199.40 million during the quarter, compared to the consensus estimate of $190.19 million. InnovAge had a negative trailing twelve-month return on equity of 7.43% and a negative net margin of 2.79%. When did InnovAge IPO? InnovAge (INNV) raised $301 million in an IPO on Thursday, March 4th 2021. The company issued 16,700,000 shares at a price of $17.00-$19.00 per share. J.P. Morgan, Barclays, Goldman Sachs and Citigroup acted as the underwriters for the IPO and Baird, William Blair, Piper Sandler, Capital One Securities, Loop Capital Markets, Siebert Williams Shank and Roberts & Ryan were co-managers. Who are InnovAge's major shareholders? Top institutional investors of InnovAge include Renaissance Technologies LLC (0.10%), Accordant Advisory Group Inc (0.07%), Bank of New York Mellon Corp (0.04%) and Rhumbline Advisers (0.02%). How do I buy shares of InnovAge? Shares of INNV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:INNV) was last updated on 9/16/2024 by MarketBeat.com Staff From Our PartnersBiden's Executive Order, Dems Digital Money Legislation, First Step ToDonald Trump once again sounded the alarm against Fed-controlled digital currencies (CBDCs). If these plans...Monetary Gold | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredIntroducing the PerceptronOn Wednesday, September 25, I’m putting on my first crypto event in two years to unveil: the Perceptron. Th...Brownstone Research | SponsoredBREAKING NEWS: AI Tech Now Used to Stop School ShootersTwo seconds. That's all it takes for Knightscope's Automated Gunshot Detection to notify authorities and map a...Market JAR | Sponsored44-year Wall Street Vet: “Permanent devastation is coming to America”After 44 years on Wall Street, I've seen it all... Black Monday, the Great Recession, the Covid crash. B...InvestorPlace | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredPrepare for a Recession Unlike Any OtherDave Ramsey Is Dangerously Wrong And Here’s Why>> Asked whether we’re on the cusp of a US Dollar crash, Dav...American Hartford Gold Group | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding InnovAge Holding Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share InnovAge With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.